Nordisk Pharma Holding ApS — Credit Rating and Financial Key Figures
CVR number: 42848840
Stenkløvervænget 21, 2625 Vallensbæk
Income statement (kDKK)
2022 | |
|---|---|
| Fiscal period length | 12 |
| Net sales | |
| External services | -1.00 |
| Gross profit | -1.00 |
| EBIT | -1.00 |
| Pre-tax profit | -1.00 |
| Net earnings | -1.00 |
Assets (kDKK)
2022 | 2023 | 2024 | |
|---|---|---|---|
| Intangible assets total | |||
| Tangible assets total | |||
| Holdings in group member companies | 340.00 | 340.00 | 340.00 |
| Investments total | 340.00 | 340.00 | 340.00 |
| Long term receivables total | |||
| Inventories total | |||
| Short term receivables total | |||
| Balance sheet total (assets) | 340.00 | 340.00 | 340.00 |
Equity and liabilities (kDKK)
2022 | 2023 | 2024 | |
|---|---|---|---|
| Share capital | 341.00 | 341.00 | 341.00 |
| Retained earnings | -1.00 | -1.00 | |
| Profit of the financial year | -1.00 | ||
| Shareholders equity total | 340.00 | 340.00 | 340.00 |
| Non-current liabilities total | |||
| Current liabilities total | |||
| Balance sheet total (liabilities) | 340.00 | 340.00 | 340.00 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.